Clinical Trial Update: A First-in-human Study of HyperQureTM", Laparoscopic Renal Denervation Therapy in Patient With Resistant Hypertension [NA]

View source ↗

Summary

This update announces the first-in-human study of HyperQureTM laparoscopic renal denervation for resistant hypertension, sponsored by DeepQure Inc., currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Resistant Hypertension

Drugs mentioned

• HyperQureTM

Snippet

Sponsor: DeepQure Inc. | Conditions: Resistant Hypertension | NA | Status: RECRUITING